Last reviewed · How we verify

Fluarix™/Influsplit SSW® 2007/2008

GlaxoSmithKline · Phase 3 active Biologic

Fluarix™/Influsplit SSW® 2007/2008 is a Inactivated influenza vaccine Biologic drug developed by GlaxoSmithKline. It is currently in Phase 3 development for Seasonal influenza prevention in adults and children (2007/2008 season formulation).

Fluarix is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.

Fluarix is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains. Used for Seasonal influenza prevention in adults and children (2007/2008 season formulation).

At a glance

Generic nameFluarix™/Influsplit SSW® 2007/2008
SponsorGlaxoSmithKline
Drug classInactivated influenza vaccine
ModalityBiologic
Therapeutic areaImmunology / Infectious Disease
PhasePhase 3

Mechanism of action

The vaccine contains inactivated (killed) influenza virus antigens from three seasonal strains (A/H1N1, A/H3N2, and B) that trigger humoral and cellular immune responses. Upon vaccination, the body produces specific antibodies and memory immune cells that recognize and neutralize circulating influenza viruses, providing protection against infection and reducing disease severity.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fluarix™/Influsplit SSW® 2007/2008

What is Fluarix™/Influsplit SSW® 2007/2008?

Fluarix™/Influsplit SSW® 2007/2008 is a Inactivated influenza vaccine drug developed by GlaxoSmithKline, indicated for Seasonal influenza prevention in adults and children (2007/2008 season formulation).

How does Fluarix™/Influsplit SSW® 2007/2008 work?

Fluarix is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against seasonal influenza virus strains.

What is Fluarix™/Influsplit SSW® 2007/2008 used for?

Fluarix™/Influsplit SSW® 2007/2008 is indicated for Seasonal influenza prevention in adults and children (2007/2008 season formulation).

Who makes Fluarix™/Influsplit SSW® 2007/2008?

Fluarix™/Influsplit SSW® 2007/2008 is developed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).

What drug class is Fluarix™/Influsplit SSW® 2007/2008 in?

Fluarix™/Influsplit SSW® 2007/2008 belongs to the Inactivated influenza vaccine class. See all Inactivated influenza vaccine drugs at /class/inactivated-influenza-vaccine.

What development phase is Fluarix™/Influsplit SSW® 2007/2008 in?

Fluarix™/Influsplit SSW® 2007/2008 is in Phase 3.

What are the side effects of Fluarix™/Influsplit SSW® 2007/2008?

Common side effects of Fluarix™/Influsplit SSW® 2007/2008 include Injection site reactions (pain, redness, swelling), Myalgia, Headache, Fever, Fatigue.

Related